Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
1987
-
Total 13F shares, excl. options
-
1.07B
-
Shares change
-
-49.7M
-
Total reported value, excl. options
-
$98.8B
-
Value change
-
-$4.62B
-
Put/Call ratio
-
1.35
-
Number of buys
-
871
-
Number of sells
-
-902
-
Price
-
$92.65
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2018
2,138 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q2 2018.
AbbVie Inc. - Common Stock (ABBV) has 1,987 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07B shares
of 1.77B outstanding shares and own 60.36% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (194M shares), VANGUARD GROUP INC (118M shares), BlackRock Inc. (96.2M shares), STATE STREET CORP (60.8M shares), NORTHERN TRUST CORP (21.2M shares), BANK OF AMERICA CORP /DE/ (20.3M shares), GEODE CAPITAL MANAGEMENT, LLC (16.7M shares), Bank of New York Mellon Corp (15.5M shares), Orbis Allan Gray Ltd (14.7M shares), and Capital World Investors (14.5M shares).
This table shows the top 1987 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.